Tech Company Financing Transactions

Sopherion Therapeutics Funding Round

On 9/6/2004, Sopherion Therapeutics raised $47 million in Series B investment from TL Ventures, Canaan Partners and NewSpring Capital.

Transaction Overview

Announced On
9/6/2004
Transaction Type
Venture Equity
Amount
$47,000,000
Round
Series B
Proceeds Purpose
the proceeds of the Series B will be used to validate a widely applicable lead discovery platform and to fortify Sopherion's infrastructure.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
104 Carnegie Center 200
Princeton, NJ 08540
USA
Email Address
Overview
Sopherion Therapeutics, Inc. is a biopharmaceutical company focusing on the development and commercialization of anti-cancer therapies.
Profile
Sopherion Therapeutics LinkedIn Company Profile
Social Media
Sopherion Therapeutics Company Twitter Account
Company News
Sopherion Therapeutics News
Facebook
Sopherion Therapeutics on Facebook
YouTube
Sopherion Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ronald Goldfarb
  Ronald Goldfarb LinkedIn Profile  Ronald Goldfarb Twitter Account  Ronald Goldfarb News  Ronald Goldfarb on Facebook
Executive Vice President
Marcel Rozencweig
  Marcel Rozencweig LinkedIn Profile  Marcel Rozencweig Twitter Account  Marcel Rozencweig News  Marcel Rozencweig on Facebook
VP - Finance
Alina Groblicka
  Alina Groblicka LinkedIn Profile  Alina Groblicka Twitter Account  Alina Groblicka News  Alina Groblicka on Facebook
VP - Regulatory Affairs
Salvatore Forenza
  Salvatore Forenza LinkedIn Profile  Salvatore Forenza Twitter Account  Salvatore Forenza News  Salvatore Forenza on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/3/2004: MediciNova venture capital transaction
Next: 9/7/2004: Atrua Technologies venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary